These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Editorial comment. Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening. Bañez LL Urology; 2010 Nov; 76(5):e4. PubMed ID: 21056250 [No Abstract] [Full Text] [Related]
23. The effect of body mass index on PSA levels and the development, screening and treatment of prostate cancer. Skolarus TA; Wolin KY; Grubb RL Nat Clin Pract Urol; 2007 Nov; 4(11):605-14. PubMed ID: 17982437 [TBL] [Abstract][Full Text] [Related]
24. Prostatitis and prostate cancer: implications for prostate cancer screening. Kawakami J; Siemens DR; Nickel JC Urology; 2004 Dec; 64(6):1075-80. PubMed ID: 15596172 [No Abstract] [Full Text] [Related]
25. Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer. Barry MJ N Engl J Med; 2001 May; 344(18):1373-7. PubMed ID: 11333995 [No Abstract] [Full Text] [Related]
26. [Prostate-specific antigen--the most important cancer marker. Diagnostics and follow up of prostatic cancer have changed]. Bratt O; Björk T Lakartidningen; 2007 Nov 14-20; 104(46):3460-4. PubMed ID: 18072615 [No Abstract] [Full Text] [Related]
27. Prostate specific antigen: a useful screening test? Concato J Cancer J; 2000 Apr; 6 Suppl 2():S188-92. PubMed ID: 10803835 [TBL] [Abstract][Full Text] [Related] [Previous] [New Search]